LifeStance Health (LFST) Equity Ratio (2020 - 2026)

LifeStance Health (LFST) has 7 years of Equity Ratio data on file, last reported at 0.69 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.69, down 0.55% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.69 (down 0.55% YoY), and the FY2025 annual result was 0.69, up 1.08% from the prior year.
• Equity Ratio steadied at 0.69 in Q1 2026 per LFST's latest filing, from 0.69 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.79 in Q1 2022 and troughed at 0.67 in Q3 2023.
• A 5-year average of 0.7 and a median of 0.69 in 2023 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2023 and 2025: Equity Ratio dropped 13.53% in 2023, then gained 2.05% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.7 in 2022, then slipped by 3.06% to 0.68 in 2023, then rose by 0.82% to 0.68 in 2024, then increased by 1.08% to 0.69 in 2025, then retreated by 0.24% to 0.69 in 2026.
• Business Quant data shows LFST's Equity Ratio at 0.69 in Q1 2026, 0.69 in Q4 2025, and 0.69 in Q3 2025.